Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma



Lythgoe, Hanna, Baildam, Eileen, Beresford, Michael W ORCID: 0000-0002-5400-9911, Cleary, Gavin, McCann, Liza J and Pain, Clare E
(2018) Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma. RHEUMATOLOGY, 57 (2). 398 - 401.

[img] Text
Revised tocilizumab in JLS paper.docx - Accepted Version

Download (22kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 05 Dec 2017 12:54
Last Modified: 18 Dec 2019 17:15
DOI: 10.1093/rheumatology/kex382
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3013563
Repository Staff Access